Merck & Co's FDA approval for Keytruda in advanced liver cancer looks secure, after an Asian clinical trial found that the cancer immunotherapy improved survival in these patients. Keytruda ...
MSD’s checkpoint inhibitor Keytruda has been cleared by the FDA for use in newly diagnosed cervical cancer patients with less severe disease, becoming the first anti-PD-1/PD-L1 immunotherapy for ...
Camila Pérez Soto e Igna Solís Carrillo, egresadas de la Facultad de Comunicación e Imagen de la Universidad de Chile, presentan "Guardianas de la Futawillimapu. Crónicas de lucha contra la ...
Escúchanos en vivo Santiago 99.7 Valparaíso 94.5 Concepción 98.1 Los Ángeles 96.7 Temuco 88.1 Valdivia 88.9 Osorno 106.5 Puerto Montt 94.9 ...
Diplomados, congresos, cursos, talleres y workshops son parte de las alternativas de perfeccionamiento y actualización profesional.
19 March 2025 UK biotech Oxford BioTherapeutics (OBT), a clinical stage oncology company with a pipeline of immuno-oncology (I-O) and antibody drug conjugate (ADC)-based therapies, today announced a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback